From F00 l. I think they need to do some more research - nothing about Fragile X, TBI, etc.
2 growing biotech stocks for your portfolio in 2015
By now investors will have come to terms with the fact that in 2014 the gains from the S&P/ASX 200 were nothing short of lacklustre.
Despite the flat result and the less-than-rosy economic outlook for 2015 there are always ‘gems’ to be found on the stock market.
Neuren Pharmaceuticals Ltd
Having gained close to 50% in the last year, Neuren currently trades at 15.5 cents and with a market capitalisation of approximately $250 million. Neuren is hoping to develop a drug to treat Rett syndrome – a disease for which there is currently no cure.
From F00 l. I think they need to do some more research - nothing...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |